Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Malignant Lymphoma

  Free Subscription


14.04.2020

1 Am J Surg Pathol
1 BMC Cancer
1 Bone Marrow Transplant
1 Eur J Haematol
4 Haematologica
1 Int J Radiat Oncol Biol Phys
1 Lancet Oncol
3 Leuk Lymphoma
1 Leukemia
2 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg Pathol

  1. BELTZUNG F, Ortonne N, Pelletier L, Beylot-Barry M, et al
    Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group.
    Am J Surg Pathol. 2020 Apr 7. doi: 10.1097/PAS.0000000000001470.
    PubMed         Abstract available


    BMC Cancer

  2. FURUSE M, Kuwabara H, Ikeda N, Hattori Y, et al
    PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma.
    BMC Cancer. 2020;20:277.
    PubMed         Abstract available


    Bone Marrow Transplant

  3. TALLEUR AC, Flerlage JE, Shook DR, Chilsen AM, et al
    Autologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional experience.
    Bone Marrow Transplant. 2020 Apr 9. pii: 10.1038/s41409-020-0879.
    PubMed         Abstract available


    Eur J Haematol

  4. KARI EJM, Kuusisto MEL, Honkavaara P, Hakalahti A, et al
    Thioredoxin-1 as a biological predictive marker for selecting diffuse large B-cell lymphoma patients for etoposide-containing treatment.
    Eur J Haematol. 2020 Apr 5. doi: 10.1111/ejh.13419.
    PubMed         Abstract available


    Haematologica

  5. KERSTEN MJ, Driessen J, Zijlstra JM, Plattel WJ, et al
    Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.
    Haematologica. 2020 Apr 9. pii: haematol.2019.243238.
    PubMed         Abstract available

  6. ARAF S, Korfi' K, Bewicke-Copley F, Wang J, et al
    Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma.
    Haematologica. 2020 Apr 9. pii: haematol.2019.242206.
    PubMed        

  7. GARCIA-REYERO J, Martinez Magunacelaya N, Gonzalez de Villambrosia S, Loghavi S, et al
    Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma.
    Haematologica. 2020 Apr 9. pii: haematol.2020.251579.
    PubMed         Abstract available

  8. WANG L, Tang G, Medeiros LJ, Xu J, et al
    MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma.
    Haematologica. 2020 Apr 9. pii: haematol.2019.243071.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  9. WIRTH A, Mikhaeel NG, Pauline Aleman BM, Pinnix CC, et al
    Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines.
    Int J Radiat Oncol Biol Phys. 2020 Apr 6. pii: S0360-3016(20)30943.
    PubMed        


    Lancet Oncol

  10. STIRRUPS R
    CAR T-cell therapy for relapsed or refractory mantle-cell lymphoma.
    Lancet Oncol. 2020 Apr 9. pii: S1470-2045(20)30231.
    PubMed        


    Leuk Lymphoma

  11. TKACZ J, Garcia J, Gitlin M, McMorrow D, et al
    The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapy.
    Leuk Lymphoma. 2020 Apr 9:1-9. doi: 10.1080/10428194.2020.1734592.
    PubMed         Abstract available

  12. ZAYAC AS, Olszewski AJ
    Burkitt lymphoma: bridging the gap between advances in molecular biology and therapy.
    Leuk Lymphoma. 2020 Apr 7:1-13. doi: 10.1080/10428194.2020.1747068.
    PubMed         Abstract available

  13. GIFFORD GK, Gifford AJ, Chen Q, Shen Y, et al
    Fatty acid synthase and adenosine monophosphate-activated protein kinase regulate cell survival and drug sensitivity in diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2020 Apr 4:1-13. doi: 10.1080/10428194.2020.1742899.
    PubMed         Abstract available


    Leukemia

  14. NAKAMURA K, Casey M, Oey H, Vari F, et al
    Targeting an adenosine-mediated "don't eat me signal" augments anti-lymphoma immunity by anti-CD20 monoclonal antibody.
    Leukemia. 2020 Apr 8. pii: 10.1038/s41375-020-0811.
    PubMed         Abstract available


    N Engl J Med

  15. IRIARTE C, Vaitkevicius H, Marty FM, Miller AL, et al
    Missing the Target.
    N Engl J Med. 2020;382:1353-1359.
    PubMed        

  16. MAREDIA H, Rozati S
    Advanced Mycosis Fungoides.
    N Engl J Med. 2020;382:e27.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: